|
Jul 2
|
Kennedy Expands RSV Vaccine Recommendations. Moderna, Pfizer Shares Are Up.
|
|
Jul 2
|
Robert F. Kennedy Jr. Just Did The Unexpected. He Helped Moderna.
|
|
Jul 2
|
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
|
|
Jul 2
|
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
|
|
Jul 1
|
Incyte Gains 9.2% in Three Months: Buy, Hold or Sell the Stock?
|
|
Jul 1
|
Moderna Stock Gains on Encouraging Flu Vaccine Data
|
|
Jul 1
|
GSK Rebranded Flovent Asthma Inhaler For Children To Avoid $367 Million Medicaid Rebate, Senator Hassan Accuses
|
|
Jun 30
|
Gilead extends gains after Supreme Court upheld an Obamacare provision
|
|
Jun 28
|
GSK (GSK) Gains FDA Approval for Benlysta Autoinjector for Lupus Treatment
|
|
Jun 27
|
Gilead, Exact Jump After The Supreme Court Upholds A 'Cornerstone' Of Health Care
|
|
Jun 26
|
Ephicacy Appoints Névine Zariffa to Its Board of Directors
|
|
Jun 7
|
Patents and economies of scale support Pfizer's wide moat
|
|
Jun 5
|
Myriad (MYGN) Up 23.9% Since Last Earnings Report: Can It Continue?
|
|
Jun 3
|
How Moderna Went From Pandemic Hero to Vaccine Victim
|
|
Jun 2
|
Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million
|
|
May 23
|
GSK (LSE:GSK) Secures FDA Approval For COPD Treatment, Eyes European Nod For Blenrep
|
|
May 23
|
GSK plc (GSK)’s Asthma Drug Gets FDA Nod to Treat ‘Smoker’s Lung’
|
|
May 22
|
Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)
|
|
May 21
|
ATS 2025: GSK strengthens argument for twice-annual depemokimab
|
|
May 19
|
Why These 4 Women-Run Companies Deserve a Spot in Your Portfolio?
|